Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease modelDongmei Shi, Zhijun Bao, Ying Zhang et al.|Lipids in Health and Disease|2014Cited by 44
Predictors of relapse after cessation of nucleos(t)ide analog treatment in HBeAg-negative chronic hepatitis B patients: A meta-analysisYun Liu, Yifan Feng, Minglei Jia et al.|International Journal of Infectious Diseases|2019Cited by 29